Literature DB >> 18217191

Association of CC chemokine ligand 5 genotype with urinary albumin excretion in the non-diabetic Japanese general population: the Takahata study.

Tsuneo Konta1, Mitsuru Emi2, Sayumi Toriyama2, Hideto Ariumi2, Miho Ishii2, Satoshi Takasaki3, Ami Ikeda3, Kazunobu Ichikawa3, Yoko Shibata3, Noriaki Takabatake3, Yasuchika Takeishi3, Takeo Kato4, Sumio Kawata5, Isao Kubota3.   

Abstract

Albuminuria is an early marker of vascular damage, and its development in diabetic nephropathy is associated with genotype of inflammatory CC chemokine ligand 5 (CCL5). This study investigated whether the association of CCL5 and albuminuria is a general phenomenon. We characterized a Japanese population consisting of 2,749 non-diabetic individuals over 40 years in Takahata, Japan. The urine albumin-creatinine ratio (UACR) was obtained from morning spot urine. We genotyped SNPs within the CCL5 gene that displayed frequent minor allele frequencies in Japanese (i.e., rs2107538, rs2280789, rs3817655 and rs9909416). Assessment of possible association and linkage disequilibrium (LD) revealed that all four SNP genotypes are correlated significantly with UACR (P = 0.004-0.005), and these four SNPs variations showed an obvious consistency of genotypes by detecting almost complete linkage disequilibrium (D' = 1 and r (2) > 0.95). We found two exclusive haplotypes in the CCL5 gene (haplotype1: rs2107538G/rs2280789T/rs3817655T/rs9909416G, frequency 0.64 and haplotype2: rs2107538A/rs2280789C/rs3817655A/rs9909416A, frequency 0.35) among the population. A significant association with elevated UACR was identified with haplotype1 (P = 0.002). Homozygotes for haplotype1 displayed strikingly-elevated UACR (48.5 +/- 6.6 mg/g, n = 1,116) compared to the rest (28.6 +/- 1.6 mg/g, n = 1,530) (P = 0.001). In conclusion, these results suggested that genetic variation of CCL5 might be an important risk factor for albuminuria in the non-diabetic Japanese general population.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18217191     DOI: 10.1007/s10038-008-0246-6

Source DB:  PubMed          Journal:  J Hum Genet        ISSN: 1434-5161            Impact factor:   3.172


  22 in total

1.  Score tests for association between traits and haplotypes when linkage phase is ambiguous.

Authors:  Daniel J Schaid; Charles M Rowland; David E Tines; Robert M Jacobson; Gregory A Poland
Journal:  Am J Hum Genet       Date:  2001-12-27       Impact factor: 11.025

2.  Estimation of glomerular filtration rate by the MDRD study equation modified for Japanese patients with chronic kidney disease.

Authors:  Enyu Imai; Masaru Horio; Kosaku Nitta; Kunihiro Yamagata; Kunitoshi Iseki; Shigeko Hara; Nobuyuki Ura; Yutaka Kiyohara; Hideki Hirakata; Tsuyoshi Watanabe; Toshiki Moriyama; Yasuhiro Ando; Daiki Inaguma; Ichiei Narita; Hiroyasu Iso; Kenji Wakai; Yoshinari Yasuda; Yusuke Tsukamoto; Sadayoshi Ito; Hirofumi Makino; Akira Hishida; Seiichi Matsuo
Journal:  Clin Exp Nephrol       Date:  2007-03-28       Impact factor: 2.801

3.  Polymorphisms in the hANP (human atrial natriuretic peptide) gene, albuminuria, and hypertension.

Authors:  M Nannipieri; M Manganiello; A Pezzatini; A De Bellis; G Seghieri; E Ferrannini
Journal:  Hypertension       Date:  2001-06       Impact factor: 10.190

4.  Definition and classification of chronic kidney disease: a position statement from Kidney Disease: Improving Global Outcomes (KDIGO).

Authors:  Andrew S Levey; Kai-Uwe Eckardt; Yusuke Tsukamoto; Adeera Levin; Josef Coresh; Jerome Rossert; Dick De Zeeuw; Thomas H Hostetter; Norbert Lameire; Garabed Eknoyan
Journal:  Kidney Int       Date:  2005-06       Impact factor: 10.612

5.  Head-to-head juxtaposition of Fas-associated phosphatase-1 (FAP-1) and c-Jun NH2-terminal kinase 3 (JNK3) genes: genomic structure and seven polymorphisms of the FAP-1 gene.

Authors:  Shoko Yoshida; Haruhito Harada; Hisaki Nagai; Kouichi Fukino; Akira Teramoto; Mitsuru Emi
Journal:  J Hum Genet       Date:  2002       Impact factor: 3.172

Review 6.  What is the evidence that microalbuminuria is a predictor of cardiovascular disease events?

Authors:  Matthew F Yuyun; Amanda I Adler; Nicholas J Wareham
Journal:  Curr Opin Nephrol Hypertens       Date:  2005-05       Impact factor: 2.894

7.  Chemotactic cytokine receptor 5 (CCR5) gene promoter polymorphism (59029A/G) is associated with diabetic nephropathy in Japanese patients with type 2 diabetes: a 10-year longitudinal study.

Authors:  Atsuko Mokubo; Yasushi Tanaka; Kunihiro Nakajima; Hirotaka Watada; Takahisa Hirose; Masahiko Kawasumi; Ken Sakai; Akio Kanazawa; Shiro Maeda; Kazuhiro Hosokawa; Yoshihito Atsumi; Kenpei Matsuoka; Ryuzo Kawamori
Journal:  Diabetes Res Clin Pract       Date:  2006-01-25       Impact factor: 5.602

8.  RANTES promoter genotype is associated with diabetic nephropathy in type 2 diabetic subjects.

Authors:  Kunihiro Nakajima; Yasushi Tanaka; Takashi Nomiyama; Takeshi Ogihara; Fuki Ikeda; Rei Kanno; Noseki Iwashita; Ken Sakai; Hirotaka Watada; Tomio Onuma; Ryuzo Kawamori
Journal:  Diabetes Care       Date:  2003-03       Impact factor: 19.112

9.  Lipoprotein lipase gene variants relate to presence and degree of microalbuminuria in Type II diabetes.

Authors:  R K Mattu; J Trevelyan; E W A Needham; M Khan; M A Adiseshiah; D Richter; R G Murray; D J Betteridge
Journal:  Diabetologia       Date:  2002-05-23       Impact factor: 10.122

10.  Association between angiotensin-converting enzyme gene polymorphisms and diabetic nephropathy: case-control, haplotype, and family-based study in three European populations.

Authors:  Samy Hadjadj; Lise Tarnow; Carol Forsblom; Gbenga Kazeem; Michel Marre; Per-Henrik Groop; Hans-Henrik Parving; François Cambien; David A Tregouet; Ivo G Gut; Alexandre Théva; Dominique Gauguier; Martin Farrall; Roger Cox; Fumihiko Matsuda; Mark Lathrop; Nathalie Hager-Vionnet
Journal:  J Am Soc Nephrol       Date:  2007-03-21       Impact factor: 10.121

View more
  3 in total

1.  Association of chemokine CCL5 and systemic malignancies.

Authors:  Shailendra Kapoor
Journal:  J Hum Genet       Date:  2008-03-27       Impact factor: 3.172

2.  The association between genotypes of urate transporter-1, Serum uric acid, and mortality in the community-based population: the Yamagata (Takahata) Study.

Authors:  Soichiro Kon; Tsuneo Konta; Kazunobu Ichikawa; Masafumi Watanabe; Hidenori Sato; Kenichi Ishizawa; Yoshiyuki Ueno; Hidetoshi Yamashita; Takamasa Kayama
Journal:  Clin Exp Nephrol       Date:  2019-09-03       Impact factor: 2.801

3.  Inflammation gene variants and susceptibility to albuminuria in the U.S. population: analysis in the Third National Health and Nutrition Examination Survey (NHANES III), 1991-1994.

Authors:  Renée M Ned; Ajay Yesupriya; Giuseppina Imperatore; Diane T Smelser; Ramal Moonesinghe; Man-Huei Chang; Nicole F Dowling
Journal:  BMC Med Genet       Date:  2010-11-05       Impact factor: 2.103

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.